A David Burden (David A Burden, A D Burden)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Monoclonal Antibody

Top Venues

The British journal of dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

Skin health and disease

Expert review of clinical immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan N Barker, Gabrielle Becher, A David Burden, Andrew E Pink, Maria Zacharioudaki, Richard B Warren
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel. Skin health and disease 4 (3) (2024)
Jonathan N Barker, Gabrielle Becher, A David Burden, Andrew E Pink, Maria Zacharioudaki, Richard B Warren
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel. Skin health and disease 4 (3) (2024)
A David Burden
Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis. Expert review of clinical immunology (2023)
A David Burden, Yukari Okubo, M Zheng, Diamant Thaҫi, Peter Cornelis Maria van de Kerkhof, N Hu, M Quaresma, C Thoma, Siew Eng Choon
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study. Experimental dermatology (2023)
A David Burden, Robert Bissonnette, Alexander A Navarini, Masamoto Murakami, Akimichi Morita, Thomas Haeufel, Binqi Ye, Frank Baehner, Tadashi Terui
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study. Dermatology and therapy (2023)
Catherine H Smith, Zenas Zee Ngai Yiu, Tracy Bale, A David Burden, Laurence Le Cleach, Elizabeth Eckert, Nicky Longley, Satveer K Mahil, Arlene McGuire, Ruth Murphy, Catherine Nelson-Piercy, Caroline M Owen, Richard Parslew, Richard T Woolf, Zahra Mansour Kiaee, Alina M Constantin, Martinsixtus C Ezejimofor, Lesley S Exton, M Firouz Mohd Mustapa, null null
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2023 - a pragmatic update. The British journal of dermatology (2023)
A David Burden, Siew Eng Choon, Alice B Gottlieb, Alexander A Navarini, Richard Bruce Warren
Clinical Disease Measures in Generalized Pustular Psoriasis. American journal of clinical dermatology 23 (Suppl 1) (2022)
Gabrielle Becher, A David Burden
Psoriasis, COVID-19 and shielding. The British journal of dermatology 185 (1) (2021)
Kayleigh J Mason, A David Burden, Jonathan N W N Barker, Mark Lunt, H Ali, C Elise Kleyn, K McElhone, Moetaza Soliman, Adéle C Green, Christopher Ernest Maitland Griffiths, Nick J Reynolds, A D Ormerod, null null
Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Kayleigh J Mason, A David Burden, Jonathan N W N Barker, Mark Lunt, H Ali, C Elise Kleyn, K McElhone, Moetaza Soliman, Adéle C Green, Christopher Ernest Maitland Griffiths, Nick J Reynolds, A D Ormerod, null null
Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
A David Burden
Etanercept or infliximab for psoriasis? An independent randomized clinical trial. The British journal of dermatology 176 (3) (2017)